c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Cabaletta Bio (CABA) Presents Promising Phase 1/2 Data on Rese-cel Therapy at ACR Convergence 2026
GuruFocus | Nov 8, 2026 3:25 PM EST
Related Stocks: CABA ,
Read original article